Educated Patient® Prostate Cancer Summit

Common Prostate Cancer Radiation Questions Answered

November 5th 2024, 8:00pm

Article

Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.

Prostate Cancer Questions Answered, From PSA Levels to Treatment Decisions

October 29th 2024, 5:00pm

Article

An expert answers prostate cancer questions from a recent CURE Educated Patient Summit.

Treatment Side Effects, Quality of Life Factors in Prostate Cancer

October 22nd 2024, 3:00pm

Article

It’s crucial for patients with prostate cancer to know that all treatments come with side effects, which may affect their quality of life.

Rise in PSA Levels May Predict Treatment Response in Prostate Cancer

October 21st 2024, 7:00pm

Article

The rate at which PSA rises after hormonal therapy for prostate cancer is a key factor in determining the effectiveness of the treatment.

Focal Therapy May Reduce Side Effects, Improve Quality of Life in Prostate Cancer

October 18th 2024, 9:00pm

Article

With approaches like high intensity focused ultrasound, patients with prostate cancer may experience lower rates of urinary incontinence and erectile dysfunction, an expert said.

Next-Generation Imaging a ‘Gold Standard’ in Metastatic Prostate Cancer

October 16th 2024, 7:00pm

Article

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET imaging, an expert explained.

Why ‘Genetic Testing is Critical’ in Patients with Prostate Cancer

October 15th 2024, 7:00pm

Article

As part of the CURE® Educated Patient® Prostate Cancer Summit, an expert discussed the role genetic testing plays in treatment decision-making for many.

Transurethral Ultrasound Ablation a Promising Prostate Cancer Treatment

October 14th 2024, 7:00pm

Article

TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.

Educated Patient® MPN Summit Current and Future Treatments of Essential Thrombocythemia Presentation: November 19, 2022

December 11th 2022, 4:00pm

Video

Watch Dr. Douglas A. Tremblay, from Mount Sinai, discuss treatment for essential thrombocythemia during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Defining Essential Thrombocythemia Risk Presentation: November 19, 2022

December 10th 2022, 8:00pm

Video

Watch Dr. Aaron T. Gerds, from Cleveland Clinic Taussig Cancer Institute, discuss essential thrombocythemia risk during the CURE Educated Patient MPN Summit.